Unravelling the Complexity of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.
acute disseminated encephalomyelitis
acute encephalitis
autoantibodies
azathioprine treatment
demyelinating disorders
immunomodulator therapy
mogad
myelin oligodendrocyte glycoprotein
neuromyelitis optica spectrum disorder (nmosd)
optic neuritis
Journal
Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737
Informations de publication
Date de publication:
May 2024
May 2024
Historique:
accepted:
07
05
2024
medline:
10
6
2024
pubmed:
10
6
2024
entrez:
10
6
2024
Statut:
epublish
Résumé
Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is a rare autoimmune disorder characterized by recurrent episodes of demyelination affecting the central nervous system. The following case report showcases a thorough analysis of a 21-year-old female patient presenting with MOGAD, outlining her clinical presentation, diagnostic workup, treatment protocol, and long-term management outcomes. Through a multidisciplinary approach, we aim to augment the understanding of this complex neurological entity and steer optimal therapeutic interventions.
Identifiants
pubmed: 38854354
doi: 10.7759/cureus.59840
pmc: PMC11157157
doi:
Types de publication
Case Reports
Journal Article
Langues
eng
Pagination
e59840Informations de copyright
Copyright © 2024, Abbas et al.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.